메뉴 건너뛰기




Volumn 105, Issue 14, 2002, Pages 1679-1685

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-PA acute stroke survey

(69)  Tanne, David a   Kasner, Scott E a   Demchuk, Andrew M a   Koren Morag, Nira a   Hanson, Sandra a   Grond, Martin a   Levine, Steven R a   Hamilton, S A a   Hanson, S K a   Grond, M a   Grotta, J C a   Morgenstern, L a   Krieger, D a   Kasner, S E a,a   Villar, C a   Chiu, D a   Wein, T a   Hickenbottom, S a   Felberg, R a   Buchan, A M a   more..


Author keywords

Hemorrhage; Plasminogen activators; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTITHROMBOCYTIC AGENT;

EID: 0037046216     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000012747.53592.6A     Document Type: Article
Times cited : (398)

References (23)
  • 1
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • N Engl J Med
    • (1995) N Engl J Med , vol.333 , pp. 1581-1588
  • 2
    • 9544220640 scopus 로고    scopus 로고
    • Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
    • N Engl J Med
    • (1996) Stroke , vol.27 , pp. 1711-1718
    • Adams, H.P.1    Brott, T.G.2    Furlan, A.J.3
  • 4
  • 6
    • 0034161354 scopus 로고    scopus 로고
    • Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study
    • N Engl J Med
    • (2000) JAMA , vol.283 , pp. 1145-1150
    • Albers, G.W.1    Bates, V.E.2    Clark, W.M.3
  • 10
  • 11
    • 0032541845 scopus 로고    scopus 로고
    • Randomised double-blind placebo- controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
    • N Engl J Med
    • (1998) Lancet , vol.352 , pp. 1245-1251
    • Hacke, W.1    Kaste, M.2    Fieschi, C.3
  • 12
    • 0343118114 scopus 로고    scopus 로고
    • Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
    • N Engl J Med
    • (1997) Stroke , vol.28 , pp. 2109-2118
  • 13
    • 0030950928 scopus 로고    scopus 로고
    • Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European cooperative acute stroke study
    • N Engl J Med
    • (1997) Stroke , vol.28 , pp. 957-960
    • Larrue, V.1    Von Kummer, R.2    Del Zoppo, G.3
  • 15
    • 0035130531 scopus 로고    scopus 로고
    • Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
    • N Engl J Med
    • (2001) Stroke , vol.32 , pp. 438-441
    • Larrue, V.1    Von Kummer, R.2    Muller, A.3
  • 19
    • 0343990052 scopus 로고    scopus 로고
    • Generalized efficacy of tPA for acute stroke: Subgroup analysis of the NINDS tPA stroke trial
    • N Engl J Med
    • (1997) Stroke , vol.28 , pp. 2119-2125
  • 21
  • 22
    • 0032811503 scopus 로고    scopus 로고
    • Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy
    • N Engl J Med
    • (1999) Stroke , vol.30 , pp. 1528-1533
    • Grotta, J.C.1    Chiu, D.2    Lu, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.